|Articles|April 8, 2019
Utilizing an Integrated, Multi-Channel Approach Can Improve Access for Oncology Products
Author(s)McKesson Life Sciences
How biopharma companies can pursue multiple channels to enhance access to segmented markets.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: Johnson & Johnson Collaborates with Sail Biomedicines, Processa Pharmaceuticals Acquires Vidya Therapeutics, Relation Collaborates with GSK
2
When Foreign Investments in Pharma and Biotech Become a National Security Concern
3
Addressing Launch Drift to Optimize Product Launches
4
What FDA's Peptide Decision Means for the Industry
5